Teacher Retirement System of Texas Reduces Stock Holdings in Ventas, Inc. $VTR

Key Points

• Teacher Retirement System of Texas cut its stake in Ventas by 12.2%, selling 30,276 shares and now holding 218,145 shares worth about $16.88 million.
• Analysts are broadly positive with a consensus rating of "Moderate Buy" (13 Buys, 3 Holds) and an average target price of $90.47, with several firms raising or reiterating targets recently.
• Ventas posted a steep quarterly EPS miss ($0.15 vs. $0.89) despite revenue rising ~21.7% YoY, has raised its quarterly dividend to $0.52 (annualized $2.08, ~2.5% yield), and saw insider selling by senior executives.

Teacher Retirement System of Texas decreased its position in Ventas, Inc. (NYSE:VTR - Free Report) by 12.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 218,145 shares of the real estate investment trust's stock after selling 30,276 shares during the period. Teacher Retirement System of Texas' holdings in Ventas were worth $16,880,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Cloud Capital Management LLC bought a new stake in Ventas during the 3rd quarter valued at $25,000. GoalVest Advisory LLC bought a new stake in Ventas during the 4th quarter valued at $26,000. Wiser Advisor Group LLC bought a new stake in Ventas during the 3rd quarter valued at $27,000. True Wealth Design LLC raised its holdings in Ventas by 1,557.7% during the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust's stock valued at $30,000 after acquiring an additional 405 shares during the period. Finally, ORG Partners LLC raised its holdings in Ventas by 76.1% during the 3rd quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust's stock valued at $32,000 after acquiring an additional 197 shares during the period. Institutional investors own 94.18% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. The Goldman Sachs Group reissued a "buy" rating and set a $100.00 target price on shares of Ventas in a report on Monday, February 9th. Morgan Stanley set a $90.00 target price on shares of Ventas in a report on Friday, February 13th. Royal Bank Of Canada boosted their target price on shares of Ventas from $83.00 to $91.00 and gave the company an "outperform" rating in a report on Tuesday, February 10th. Mizuho upped their price target on shares of Ventas from $87.00 to $94.00 and gave the stock an "outperform" rating in a report on Wednesday, March 4th. Finally, Scotiabank upped their price target on shares of Ventas from $80.00 to $93.00 and gave the stock a "sector perform" rating in a report on Monday, March 2nd. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $90.47.

Ventas Trading Up 1.0%

Ventas stock opened at $83.75 on Friday. The stock has a market cap of $39.82 billion, a P/E ratio of 155.09, a PEG ratio of 2.04 and a beta of 0.75. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $88.36. The firm's fifty day moving average price is $84.70 and its 200-day moving average price is $79.51. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67.

Ventas (NYSE:VTR - Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). The firm had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The company's revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities research analysts forecast that Ventas, Inc. will post 3.85 earnings per share for the current fiscal year.

Ventas Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were issued a $0.52 dividend. The ex-dividend date of this dividend was Tuesday, March 31st. This is an increase from Ventas's previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Ventas's payout ratio is currently 385.19%.

Insiders Place Their Bets

In related news, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the transaction, the executive vice president owned 72,755 shares of the company's stock, valued at $6,184,175. This represents a 32.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their position. The SEC filing for this sale provides additional information. 0.53% of the stock is owned by corporate insiders.

About Ventas

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.